SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

NCT06288893 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SHEN211 Tablets
PROCEDURE: Placebo for SHEN211 Tablets

Sponsor

JKT Biopharma Co., Ltd.